289例乙型肝炎肝硬化患者肾功能评估

doi:10.3969/j.issn.1672-5069.2017.04.012

摘要/Abstract

摘要： 目的分析不同的肾功能评估方法对289例乙型肝炎肝硬化患者肾功能评估的差异,并探讨患者发生肾功能不全的危险因素。方法 2015年1月~2015年12月于安徽医科大学第一附属医院感染病科住院的乙型肝炎肝硬化患者,分别采用血肌酐（sCr）、内生肌酐清除率（CCr）、估算的肾小球滤过率（eGFR）评估患者肾功能。对不同Child-Pugh分级患者肾功能不全程度进行评估,采用Logistic回归分析筛选出肾功能不全发生的危险因素。结果纳入289例乙型肝炎肝硬化患者,其中Child-Pugh A级患者95例,Child-Pugh B级患者122例,Child-Pugh C级患者72例。以eGFR<90 ml.min^-1.1.73 m²为肾功能不全的判断标准,结果在本组患者中发现肾功能不全发生率为20.76%,显著高于采用sCr评估出的3.81%或cCr评估出的13.15%（P<0.05）;Child-Pugh C级患者肾功能不全发生率为29.17%,显著高于Child-Pugh A级的13.68%或Child-Pugh B级的21.31%（P<0.05）;单因素Logistic回归分析提示年龄、Child-Pugh分级、高尿酸血症、低钠血症与肾功能不全的发生有关,而多因素Logistic回归分析结果显示年龄、高尿酸血症和低钠血症是乙型肝炎肝硬化患者发生肾功能不全的独立危险因素（P<0.05）。结论 eGFR较sCr或cCr能更早地反映出乙型肝炎肝硬化患者是否存在肾功能不全,乙型肝炎肝硬化患者肾功能不全程度与Child-Pugh分级有关,但高龄、高尿酸血症和低钠血症是其发生的独立危险因素。

关键词: 肝硬化, 慢性乙型肝炎, 估算的肾小球滤过率, 肾功能不全, 危险因素

Abstract: Objective To investigate the prevalence of renal function insufficiency in patients with hepatitis B（HB） related cirrhosis and to explore the risk factors for renal insufficiency. Methods 289 patients with HB-related cirrhosis were recruited in our hospital between Jan.2015 and Dec. 2015. The renal function was evaluated by serum creatinine（sCr）,endogenous creatinine clearance （cCr） or the estimated glomerular filtration rate （eGFR） levels. The risk factors affecting renal function were screened by applying Logistic regression analysis. Results A total of 289 hospitalized patients with HB-related cirrhosis were enrolled,including 95 Child-Pugh class A,122 Child-Pugh class B and 72 Child-Pugh class C. The incidence of renal insufficiency assessed by eGFR as <90 ml·min^-1·1.73 m² was 20.76%,significantly higher than 3.81% assessed by sCr or 13.15% by cCr（P<0.05）;the incidence of renal insufficiency in Child-Pugh class C was 29.17%,significantly higher than 13.68% in Child-Pugh class A or 21.31% in Child-Pugh class B（P<0.05）;Univariate Logistic regression analysis showed that age,Child-Pugh classification,hyperuricemia and hyponatremia were related to the occurrence of renal insufficiency,while multivariate Logistic regression analysis identified age,hyperuricemia and hyponatremia as independent risk factors for renal insufficiency,in patients with hepatitis B-related cirrhosis（P<0.05）. Conclusion eGFR assessment might reflect the existence of renal insufficiency earlier than by sCr or cCr assessment. Development of renal insufficiency in patients with hepatitis B-related cirrhosis is associated with Child-Pugh scores,while age,hyperuricemia and hyponatremia are independent risk factors for the occurrence of renal injuries.

Key words: Liver cirrhosis, Hepatitis B, Estimated glomerular filtration rate, Renal insufficiency, Risk factors

孙雅凤, 李家斌. 289例乙型肝炎肝硬化患者肾功能评估[J]. 实用肝脏病杂志, 2017, 20(4): 427-430.

Sun Yafeng, Li Jiabin.. Evaluation of renal function in 289 patients with hepatitis B cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 427-430.

参考文献

[1] Fattovich G,Bortolotti F,Donato F. Natural history of chronic hepatitis B:special emphasis on disease progression and prognostic factors. J Hepatol,2008,48（2）:335-352.
[2] Tsien C D,Rabie R,Wong F. Acute kidney injury in decompensated cirrhosis. Gut,2013,62（1）:131-137.
[3] Fagundes C,Ginès P. Hepatorenal syndrome:a severe,but treatable,cause of kidney failure in cirrhosis. Am J Kidney Dis,2012,59（6）:874-885.
[4] 黄娟,陈东风. 乙肝相关性肾小球肾炎研究进展.胃肠病学和肝病学杂志,2015,21（3）:267-269.
[5] Pugh RNH,Murray-Lyon IM,Dawson J L,et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg,1973,60（8）:646-649.
[6] Combes B,Shorey J,Barrera A,et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet,1971,298（7718）:234-237.
[7] Diao Z,Ding J,Yin C,et al. Purified hepatitis B virus induces human Mesangial cell proliferation and extracellular matrix expression In Vitro. Virol J,2013,10（1）:300.
[8] Arroyo V,Fernández J. Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol,2011,7（9）:517-526.
[9] Bolognesi M,Di Pascoli M,Verardo A,et al. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol,2014,20（10）:2555-2563.
[10] Diao TJ,Chen X,Deng LH,et al. Protective effect of nitric oxide on hepatopulmonary syndrome from ischemia-reperfusion injury. World J Gastroenterol,2012,18（25）:3310-3316.
[11] Wadei HM,Gonwa TA. Hepatorenal syndrome in the intensive care unit. J Inten Care Med,2013,28（2）:79-92.
[12] European Association For The Study Of The Liver. EASL clinical practice guidelines:Management of chronic hepatitis B virus infection. J Hepatol 2012,57（1）:167-185.
[13] Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology,2006,131（6）:1743-1751.
[14] Mauss S,Berger F,Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. Aids,2005,19（1）:93-95.
[15] Gane EJ,Deray G,Liaw YF,et al. Telbivudine improves renal function in patients with chronic hepatitis B. Gastroenterology, 2014,146（1）:138-146. e5.
[16] 易富,蔡敏琪,梁凯,等. 955例HBV感染者肾功能损害的分析. 重庆医学,2012,23（9）:909-910.
[17] Weiner DE,Tighiouart H,Elsayed EF,et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol,2008,19（6）:1204-1211.
[18] Janicko M,Veselíny E,Abraldes JG,et al. Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndrome. Zeitschrift für Gastroenterol,2013,51（7）:628-634.
[19] 吴小倩,苏菲. 失代偿期肝硬化患者急性肾损伤相关危险因素分析. 实用肝脏病杂志,2014,17（4）:360-363.
修稿：2017-02-18